HELSINKI, Finland – Euformatics, a Finnish software company specialising in bioinformatics for genomic applications, has appointed Tommi Kaasalainen as its new CEO as of September 21st 2020. Olli Pasanen has stepped down from the position of CEO but will continue to play an integral role in the operation of the company as Chairman of the Board. Tommi brings with […]
Additional development projects planned to accelerate QIAGEN’s Sample to Insight workflows through delivery of digital laboratory tools. L7 Informatics, provides software and services that enable synchronized solutions for scientific research and development. L7’s Enterprise Science Platform (ESP) is a scientific information management (SIM) solution that enables crop science companies to connect wet lab, greenhouses, sequencing […]
DUBLIN, Ireland: ERS Genomics Limited (“ERS”), which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property (IP) co-owned by Dr. Emmanuelle Charpentier, today announced the appointment of Michael Arciero as Vice-President of Intellectual Property and Commercial Development. In the new role, Michael will oversee the intellectual property portfolio of the company and will […]
Genetics Research, LLC (“GR”), a privately-held company developing a portfolio of novel and proprietary CRISPR-associated technologies for targeted DNA enrichment, announced today that it has licensed certain of its patents relating to this technology to Oxford Nanopore Technologies, Ltd. (“Oxford Nanopore”) based in Oxford, United Kingdom. This license enables Oxford Nanopore to use GR patents […]
Expanding Bio-Techne’s lead in providing multi-omics research tools to co-detect RNA and protein targets MINNEAPOLIS — Bio-Techne Corporation (NASDAQ:TECH) today announced the expansion of the Advanced Cell Diagnostics (ACD)-branded RNAscope™ technology with release of the new RNA-Protein Co-Detection Assays. The RNAscope technology is an advanced in situ hybridization (ISH) assay that enables visualization of single-molecule […]
Cambridge, United Kingdom – Congenica, a digital health company enabling rapid and accurate analysis of complex genomic data, has launched a new module for its genomic analysis platform that will accelerate research into the relationship between an individual’s genomic variation and COVID-19 susceptibility, severity, and clinical outcomes. Since the beginning of the COVID-19 global pandemic outbreak, the […]
MINNEAPOLIS — Bio-Techne Corporation (NASDAQ: TECH) today announced that the B-MoGen Biotechnologies portfolio of genome engineering services, GMP therapeutic manufacturing services, and its proprietary transposon-transposase gene transfer system, TcBuster™, will be rebranded as R&D Systems. As part of the rebranding, the B-MoGen Biotechnologies website will be retired. Service details and purchasing options will be maintained […]
LONGMONT, Colo. — KromaTiD, Inc. today announced the appointment of Vic Myer to its Board of Directors. Dr. Myer joins KromaTiD’s Board with extensive experience in technology, R&D and pharmaceutical company executive leadership, including 5 years of experience as Chief Technology Officer of Editas Medicine, a leading developer of gene editing-based therapies. He is currently Entrepreneur in Residence […]
Solution Receives AOAC® PTM SM Certification WALTHAM, Mass. – PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today launched the PerkinElmer Solus Listeria monocytogenes ELISA Assay. This new offering will help high throughput food processors and contract labs focus on L. mono testing for food and environmental surface samples. In sync with leading industry […]
Total RNA is comprised of large amounts of undesired transcripts, such as ribosomal RNA (rRNA), which account for ~80-98 % of the total RNA sample, and globin mRNA, accounting for ~35-80 % of mRNA in blood samples. Therefore, RNA sample preparation for sequencings requires stringent rRNA and (for blood samples) globin depletion. The upgraded version […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
